NOTICE for Suspension of Competition for PAR-10-218, Phase II International Implementation, Clinical, Operational, and Health Services Research Training Award for AIDS and Tuberculosis (U2R) for the FY 2012 Funding Cycle


Notice Number: NOT-TW-11-004

Update: The following update relating to this announcement has been issued:

  • March 9, 2011 - See Notice NOT-TW-11-014 Notice to Discontinue PAR-10-218.
  • February 16, 2011 - See Notice NOT-TW-11-010 Fogarty International Center to Consolidate HIV Research Training Programs.
Key Dates

Release Date: December 13, 2010

Related Notices

NOT-TW-10-006
NOT-TW-11-005

Issued by

Fogarty International Center (FIC)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute on Dental and Craniofacial Research (NIDCR)
National Institute on Drug Abuse (NIDA)

Purpose

This notice is to inform potential applicants that the competition for the Phase II International Implementation, Clinical, Operational, and Health Services Research Training Award for AIDS and Tuberculosis Program (U2R) has been suspended for the FY 2012 funding cycle.

No applications will be accepted in response to PAR-10-218, Phase II International Implementation, Clinical, Operational, and Health Services Research Training Award for AIDS and Tuberculosis (U2R) http://grants.nih.gov/grants/guide/pa-files/PAR-10-218.html in 2011. The previously scheduled application receipt date, August 16, 2011 will not be active.

FIC is in the process of considering the re-organization and re-configuration of its HIV research training programs (see NOT-TW-10-006- http://grants.nih.gov/grants/guide/notice-files/NOT-TW-10-006.html). Future directions for this program will be announced in the NIH Guide when the planning process is completed.

Inquiries

Please direct all inquiries to:

Jeanne McDermott
Division of International Training and Research
Fogarty International Center, NIH
Building 31, Room B2-C39
31 Center Drive, MSC-2220
Bethesda, MD 20892-2220 USA
Phone: 301-496-1492
Fax: 301-402-0779
Email: [email protected]